We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$211M
AUM Growth
+$6.73M
Cap. Flow
-$2.71M
Cap. Flow %
-1.29%
Top 10 Hldgs %
63.4%
Holding
52
New
2
Increased
11
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
FIVE icon
Five Below
FIVE
+$4.17M
2
DIS icon
Walt Disney
DIS
+$3.98M
3
NVDA icon
NVIDIA
NVDA
+$232K
4
AEP icon
American Electric Power
AEP
+$200K
5
NEE icon
NextEra Energy
NEE
+$155K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.96M
2
BIIB icon
Biogen
BIIB
+$2.21M
3
GILD icon
Gilead Sciences
GILD
+$710K
4
ALXN
Alexion Pharmaceuticals
ALXN
+$537K
5
SBUX icon
Starbucks
SBUX
+$343K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.72%
2 Technology 26.12%
3 Healthcare 23.31%
4 Communication Services 13.52%
5 Industrials 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
51
SLB Ltd
SLB
$76.5B
– –
-4,624
Closed -$201K
CELG
52
DELISTED
Celgene Corp
CELG
– –
-52,623
Closed -$4.96M
1 2
3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Bender Robert & Associates held 52 positions worth $211M, up 3.3% from $204M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bender Robert & Associates's Q2 2019 filing shows 2 new, 11 increased, 33 reduced and 3 closed positions. Its largest new stake was Five Below: 31,662 shares worth $3.85M. The largest sale was Celgene Corp, an estimated $4.96M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.

  • Bender Robert & Associates's largest Q2 2019 buy was Five Below: 31,662 shares worth $3.85M.
  • Bender Robert & Associates added most to Walt Disney in Q2 2019, an estimated $3.98M increase.
  • Bender Robert & Associates's biggest Q2 2019 reduction was Gilead Sciences, cutting an estimated $710K.
  • Bender Robert & Associates fully exited Celgene Corp in Q2 2019, selling an estimated $4.96M.
  • Bender Robert & Associates's ten largest holdings make up 63% of its $211M portfolio in Q2 2019.
  • Bender Robert & Associates opened 2 new positions and closed 3 in Q2 2019.
  • Bender Robert & Associates's portfolio value rose 3.3% quarter-over-quarter to $211M.

Based on Bender Robert & Associates's 13F filing for Q2 2019, filed 30 Jul 2019.